Ether

Ether

SCHEMBL1280469

CCO.CCOCC.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL10962604 0.96 ALDH1A1 (0.50)
Ether SCHEMBL5597265 0.96 ALDH1A1 (0.56)
Ether SCHEMBL6581224 0.96 ALDH1A1 (0.56)
Ether SCHEMBL27267758 0.96 ALDH1A1 (0.56)
Ether SCHEMBL9058622 0.96 ALDH1A1 (0.56)
Ether SCHEMBL9688867 0.96 ALDH1A1 (0.56)
Ether SCHEMBL2801167 0.96 ALDH1A1 (0.56)
Ether SCHEMBL5693230 0.96 ALDH1A1 (0.56)
Ether SCHEMBL9321955 0.96 ALDH1A1 (0.56)
Ether SCHEMBL1797 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108499544-B Preparation method of polystyrene microsphere cellulose-based heavy metal adsorbent 广西大学 2020-12-01 CN claimed
CN-117470746-A Rapid visual inspection method for sun-screening effect of sun-screening product and application thereof 广州雅纯化妆品制造有限公司 2024-01-30 CN disclosed
EP-2858989-B9 AMORPHOUS FORM OF AN AKT INHIBITING PYRIMIDINYL-CYCLOPENTANE COMPOUND, COMPOSITIONS AND METHODS THEREOF GENENTECH INC (US) 2021-04-14 EP disclosed
CN-108499544-B Preparation method of polystyrene microsphere cellulose-based heavy metal adsorbent 广西大学 2020-12-01 CN disclosed
EP-3719014-A1 SOLID FORMS OF AN AKT INHIBITING PYRIMIDINYL-CYCLOPENTANE COMPOUND, COMPOSITIONS AND METHODS THEREOF Genentech, Inc. (US) 2020-10-07 EP disclosed
EP-2858989-B1 AMORPHOUS FORM OF AN AKT INHIBITING PYRIMIDINYL-CYCLOPENTANE COMPOUND, COMPOSITIONS AND METHODS THEREOF GENENTECH INC (US) 2020-05-06 EP disclosed
US-9932443-B2 Peptide-based materials UNIVERSITY OF SOUTH FLORIDA (US) 2018-04-03 US disclosed
US-9505725-B2 Crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof GENENTECH, INC. (US) 2016-11-29 US disclosed
WO-2016091387-A1 SALTS OF IDELALISIB RATIOPHARM GMBH (DE) 2016-06-16 WO disclosed
EP-3031808-A1 Salt of idelalisib ratiopharm GmbH (DE) 2016-06-15 EP disclosed
US-5358949-A Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-10-25 US disclosed
US-5306720-A Treatment of cerebrovascular disorders EISAI CO., LTD. (JP) 1994-04-26 US disclosed
EP-0229391-B1 PIPERIDINE DERIVATE, ITS USE AND PHARMACEUTICAL COMPOSITION CONTAINING IT Eisai Co., Ltd. (JP) 1992-07-29 EP disclosed
US-5118684-A For cardiovascular disorder EISAI CO., LTD. (JP) 1992-06-02 US disclosed
US-5039681-A Cognition activators, brain disorders, psychology EISAI CO., LTD. (JP) 1991-08-13 US disclosed
US-4942169-A COGNITION ACTIVATORS, ANTICHOLINESTERASE EISAI CO., LTD. (JP) 1990-07-17 US disclosed
US-4882330-A 1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents A. H. ROBINS COMPANY, INCORPORATED (US) 1989-11-21 US disclosed
US-4849431-A ANTICHOLINESTERASE ACTIVITY EISAI CO., LTD. (JP) 1989-07-18 US disclosed
US-4806555-A CARDIAC ARRHYTHMIA INHIBITOR A. H. ROBINS COMPANY, INCORPORATED (US) 1989-02-21 US disclosed
EP-0269383-A2 1-Aryloxy-4-[(4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents A.H. ROBINS COMPANY, INCORPORATED (US) 1988-06-01 EP disclosed